🇺🇸 FDA
Patent

US 11248213

Platform for generating safe cell therapeutics

granted A61KA61K2039/515A61K2039/545

Quick answer

US patent 11248213 (Platform for generating safe cell therapeutics) held by The Regents of the University of California expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/515, A61K2039/545, A61K35/12, A61K35/17